Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors
about
Hatching enzymes disrupt aberrant gonadal degeneration by the autophagy/apoptosis cell fate decisionIntracellular activation of ovastacin mediates pre-fertilization hardening of the zona pellucida.Evaluation of SAS1B as a target for antibody-drug conjugate therapy in the treatment of pancreatic cancer.
P2860
Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Membrane associated cancer-ooc ...... utic target for uterine tumors
@ast
Membrane associated cancer-ooc ...... utic target for uterine tumors
@en
type
label
Membrane associated cancer-ooc ...... utic target for uterine tumors
@ast
Membrane associated cancer-ooc ...... utic target for uterine tumors
@en
prefLabel
Membrane associated cancer-ooc ...... utic target for uterine tumors
@ast
Membrane associated cancer-ooc ...... utic target for uterine tumors
@en
P2093
P2860
P356
P1433
P1476
Membrane associated cancer-ooc ...... utic target for uterine tumors
@en
P2093
Alain Gougeon
Amir A Jazaeri
Arabinda Mandal
Austin K Herr
Brian A Pollok
Charles J Flickinger
David E Bruns
Eusebio S Pires
John C Herr
P2860
P304
30194-30211
P356
10.18632/ONCOTARGET.4734
P407
P577
2015-08-18T00:00:00Z